Content Hubs and Community Roundtables
An exclusive opportunity for DIA Community Members.
Content Hubs and Community Round Table Discussions are designed to encourage thought-sharing and collaboration with members of DIA Communities.
Content Hubs
Have 30 minutes? Join in on a conversation and come away with new perspectives!
This non-traditional learning/networking hybrid is specifically designed for small groups to connect with others that share the same interests. Interact with community leaders and have meaningful discussions to gain rapid insight in a subject of value.
Community Roundtable Discussions
DIA Community members will host round table discussions inspired by sessions from within the DIA 2024 program agenda. Community Roundtable Discussions are designed to carry learning and debate from sessions to real-life application and discussion. Many of the discussions will include Session Chairs and speakers.
Agenda
-
Roundtable Discussion:
The Interaction of Science, Ethics, and Patient Collaboration in Pediatric Rare Disease Product Development
VIEW
-
Roundtable Discussion:
Interactive Safety Graphics in the Regulatory Decision-Making Process
VIEW -
Roundtable Discussion:
The State of Real-World Evidence for Regulatory Decision-Making - Views from FDA, EMA, and PMDA
VIEW -
Roundtable Discussion:
Innovation in Manufacturing Globally
VIEW -
Roundtable Discussion:
Be Creative and Innovative - A Simple Step-by-Step Decision Science Based Process for You and Your Team
VIEW -
Roundtable Discussion:
Good Data Governance Practices and the Importance of Incorporating Input from the Data Scientist in Quality by Design
VIEW -
Roundtable Discussion:
Supporting Regulatory Convergence and Reliance Through a Pharmaceutical Quality Knowledge Management Capability
VIEW
-
Roundtable Discussion:
The Evolving Role of Artificial Intelligence in the Medicinal Product Lifecycle
VIEW -
Roundtable Discussion:
AI Process in Medical Writing, AI Utilization, and AI Real-World Use Cases
VIEW -
Roundtable Discussion:
Securing the Chain - US and EU Legislative Reforms and Regulatory Actions for Drug Shortage Mitigation
VIEW -
Roundtable Discussion:
The Chatbot Will See You Now - Ethical Considerations in Incorporating AI in Informed Consent
VIEW -
Roundtable Discussion:
Leveraging Cloud-Based Technologies to Accelerate Reliance and Convergence - An Industry and Regulatory Agency Experience
VIEW